Cargando...
Global Manufacturing of CAR T Cell Therapy
Immunotherapy using chimeric antigen receptor-modified T cells has demonstrated high response rates in patients with B cell malignancies, and chimeric antigen receptor T cell therapy is now being investigated in several hematologic and solid tumor types. Chimeric antigen receptor T cells are generat...
Gardado en:
| Publicado en: | Mol Ther Methods Clin Dev |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
American Society of Gene & Cell Therapy
2016
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5363291/ https://ncbi.nlm.nih.gov/pubmed/28344995 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omtm.2016.12.006 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|